セッション |
検索結果は5件です。
- Is the WHO 2010 classification sufficient to clearly characterize pancreatic neuroendocrine carcinoma?
-
Hijioka Susumu(Department of Gastroenterology, Aichi Cancer Center Hospital, Japan)
Background:The WHO 2000 classification of pancreatic neuroendocrine tumors(pNET)addressed morphological differentiation as the first criterion;however, the 2010 classification is based on histo...
第100回日本消化器病学会総会 >
Short Oral Presentations(Pancreaticobiliary disorders 2)
- Pancreatic Ductal Adenocarcinoma(PDAC):Identification of compounds that inhibit NUPR1 protein function in cell culture
-
Abian Olga(Aragon Health Science Institute, Spain)
Because pancreatic cancer is often diagnosed at a late stage, surgical removal of the tumor is often difficult, if not impossible. Pancreatic ductal adenocarcinoma, or PDAC, is by far the most common ...
第100回日本消化器病学会総会 >
Short Oral Presentations(Pancreaticobiliary disorders 2)
- Loss of runt-related transcription factor 3 induces gemcitabine resistance via increasing the expression of multidrug resistant protein in pancreatic cancer
-
Horiguchi Shigeru(Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine, Japan)
Background and Aim:Runt-related transcription factor 3(RUNX3)is a tumor suppressor gene discovered in gastric cancer. RUNX3 is lost or decreased in various cancer tissues, including pancreatic ...
第100回日本消化器病学会総会 >
Short Oral Presentations(Pancreaticobiliary disorders 2)
- Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts
-
Kanda Mitsuro(Department of Gastroenterological Surgery(Surgery II), Nagoya University Graduate School of Medicine, Japan)
Objective;Pancreatic cysts are commonly detected in patients undergoing pancreatic imaging. Better approaches are needed to characterise these lesions. In this study we evaluated the utility of...
第100回日本消化器病学会総会 >
Short Oral Presentations(Pancreaticobiliary disorders 2)
- Investigation of biological characteristics of biliary tract cancers to establish a novel molecular-targeted therapy
-
Yokoyama Masaaki(Kyorin University, Japan)
<Purpose> The purpose of this study is to investigate various genes mutations and protein overexpression in biliary tract cancer(BTC), in order to establish most optimal molecular targeted therapy....
第100回日本消化器病学会総会 >
Short Oral Presentations(Pancreaticobiliary disorders 2)
|